Healthcare -
Biotechnology - NASDAQ - US
$ 2.785
12.9 %
$ 243 M
Market Cap
-2.42
P/E
TERN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities TERN - Terns Pharmaceuticals, Inc.
-12.4 M
LAST VALUE
25.35%
2 YEAR CAGR
-26.34%
5 YEAR CAGR
0.00%
10 YEAR CAGR